Home Business & Economics

Business & Economics

Three Recommendations to Better Understand HIPAA Compliance

According to the United States Department of Health and Human Services, approximately 70% of organizations are not HIPAA Compliant. 

Daiichi Sankyo Accelerates Biologics License Application for Trastuzumab Deruxtecan

Japaneses drug-maker Daiichi Sankyo announced plans to accelerate filing of their Biologics License Application (BLA) with the U.S. Food and ...

Lonza’s Cocoon Platform Brings Automated Cell-Therapy Manufacturing to the Clinic

A collaboration between Swiss-based Lonza and Sheba Medical Center at Tel Hashomer, the largest hospital in Israel and the Middle East...

Bridging the Gap: My Gene Counsel and Ambry Genetics Join Forces...

My Gene Counsel and Ambry Genetics have agreed to to offer the first One-Stop Solution for direct-to-consumer (DTC) genetic test results confirmed...

The Fear Insurance Will Not Cover

We purchase insurance to reduce fear. The fear that an unusual/rare event will devastate us financially. Homeowner’s insurance, to remove the fear of economic...

Studies on Origins of Colon Cancer may Lead to New and...

Senior Research Scientist Bruce Boman, MD, Ph.D., MSPH, FACP, at the Helen F. Graham Cancer Center & Research Institute of Christiana Care Health System...

FDA Approves Samsung Bioepis’ First Oncology Biosimilar Trastuzumab-dttb

The U.S. Food and Drug Administration (FDA) has approved trastuzumab-dttb (Ontruzant®; Samsung Bioepis) a biosimilar referencing* trastuzumab (Herceptin®; Genentech/Roche), for adjuvant treatment of HER2-overexpressing...

Financial Toxicity: Privately Insured Cancer Survivors Carry Greater Medical Debt

Younger cancer survivors have are facing significant hardship as a result of their cancer treatment. A recent study also shows that cancer survivors in...

Lonza and Takeda Bring Cancer Treatment to Patients

European Commission has approved brigatinib (Alunbrig®; Takeda), a once-daily tablet for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+)...

Bristol-Myers Squibb and Celgene Merge

Bristol-Myers Squibb Company (headquartered in New York, New York) and Celgene Corporation (headquartered in Summit, New Jersey) have entered into a definitive merger agreement...

Latest